Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -70.73x is 25% above its 2-year average of -93.97x, near the high end of its 2-year range (-137.31x–-58.32x).
As of the fiscal period ended Friday, March 31, 2023. 8.27% above its 12-month average of -77.10x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2023 (2023-03-31): -70.73x.
INTEREST COVERAGE RATIO
-70.73x
INTEREST COVERAGE RATIO AVG TTM
-77.10x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+8.27%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-1009.42%
vs the sector median at left
Korro Bio, Inc.
Market Cap
$97.14M
Interest Coverage Ratio
-70.73x
TTM Avg
-77.10x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$97.94M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$95.14M
Interest Coverage Ratio
-16.28x
TTM Avg
11.76x
3Y Avg
11.76x
5Y Avg
11.76x
Market Cap
$99.62M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$93.96M
Interest Coverage Ratio
2.53x
TTM Avg
4.25x
3Y Avg
3.46x
5Y Avg
3.46x
Market Cap
$101.36M
Interest Coverage Ratio
N/A
TTM Avg
2.91x
3Y Avg
2.91x
5Y Avg
2.91x
Market Cap
$102.75M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$103.14M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Korro Bio, Inc. (KRRO) | $97.14M | -70.73x | -77.10x | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $97.90M | -48.13x | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $97.94M | N/A | N/A | N/A | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $95.14M | -16.28x | 11.76x | 11.76x | 11.76x |
| OnKure Therapeutics, Inc. (OKUR)vs › | $99.62M | N/A | N/A | N/A | N/A |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.96M | 2.53x | 4.25x | 3.46x | 3.46x |
| The Joint Corp. (JYNT)vs › | $101.36M | N/A | 2.91x | 2.91x | 2.91x |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.75M | N/A | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $103.14M | N/A | N/A | N/A | N/A |
| Rallybio Corporation (RLYB)vs › | $90.64M | N/A | N/A | N/A | N/A |
Interest Coverage
-70.7x
Debt/Equity
0.41
Current Ratio
9.55
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-03-31 | -70.73x |
| 2022-12-31 | -58.32x |
| 2022-09-30 | -77.09x |
| 2022-06-30 | -102.27x |
| 2021-12-31 | -117.36x |
| 2021-09-30 | -137.31x |
| 2021-06-30 | -96.06x |
| 2021-03-31 | -92.66x |
